Literature DB >> 24021253

Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.

Dana Meaney-Delman1, Cecelia A Bellcross.   

Abstract

An understanding of the diagnosis and clinical management of hereditary breast and ovarian cancer syndrome (HBOC) is essential for obstetricians/gynecologists. This article provides practical information regarding collecting a family history, cancer risk assessment and genetic testing, BRCA-associated cancer prognosis and treatment, screening recommendations, and prevention strategies. Through appropriate cancer risk assessment, women with BRCA1/2 mutations can be identified, and screening and prevention strategies can be used before a diagnosis of cancer occurs. Women's health providers with a strong working knowledge of HBOC are able to improve the quality of care for women and families impacted by BRCA1/2 mutations. Published by Elsevier Inc.

Entities:  

Keywords:  BRCA1; BRCA2; Clinical management; Genetic testing; Hereditary breast cancer; Hereditary ovarian cancer

Mesh:

Substances:

Year:  2013        PMID: 24021253     DOI: 10.1016/j.ogc.2013.05.009

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  2 in total

Review 1.  Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.

Authors:  George U Eleje; Ahizechukwu C Eke; Ifeanyichukwu U Ezebialu; Joseph I Ikechebelu; Emmanuel O Ugwu; Onyinye O Okonkwo
Journal:  Cochrane Database Syst Rev       Date:  2018-08-24

2.  Peritoneal cancer after bilateral mastectomy, hysterectomy, and bilateral salpingo-oophorectomy with a poor prognosis: A case report and review of the literature.

Authors:  Ya-Na Ma; Hua-Lei Bu; Cheng-Juan Jin; Xia Wang; You-Zhong Zhang; Hui Zhang
Journal:  World J Clin Cases       Date:  2019-11-26       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.